Full programme:

DAY 1: The implications of transgenic technology for the agricultural economy, health and environment, and policy & regulation

Prof. Han Jianguo (NSFC), Welcome and introduction - View Han presentation

Session I:  Retrospects and prospects
Chair: Prof. Li Zhen

Robin Williams (Innogen), “Understanding the context of British and European responses to life science technologies"
View Williams presentation

Steve Hughes (Egenis), “Changing Trends and Fortunes for Genomics in European Crop Plant Science since the Late 1980s”
View Hughes presentation

Yang Litao; Zhang Dabing; Li Zhen (Shanghai Jiao Tong University), “Analysis for Genetically Modified Organism in China”
View Yang presentation

Session II: Social, economic, environmental, ethical (etc.) implications
Chair: Prof. Yufa Peng

Zhu Zhen (Chinese Academy of Science), “Development of Transgenic Hybrid Rice with high insect-resistance”

Shen Xiaobai (Innogen), “Analysis of Transgenic Rice Development in China - A Social Shaping of Technology Perspective”
View Shen presentation

Xue Dayuan (Nanjing Institute of Environmental Science), “Social Economic Impacts for genetically-modified organisms”
View Xue presentation

Lu Baorong (Fudan University), “Potential environmental consequences caused by transgene escape from genetically modified plants through gene flow”
View Lu presentation

Peng Yufa (Chinese Academy of Agricultural Sciences), “Environmental impacts of Transgenic Cotton”
View Peng presentation

Session III:  Regulation and public policy

Peter Robbins (Innogen), “Expert and Non-expert Perceptions of the GM Crops and Food Debate: Implications for Policy and Development"
View Robbins presentation

Liu Yinliang (China University of Political Science and Law), “Regulating transgenic technology in China: Law, regulation and public policy”
View Liu presentation


DAY 2: The implications of biomedicine (including stem cell, gene therapy, new reproductive technologies etc.) for healthcare, ethics and policy & regulation

Session I:  Retrospects and prospects

Shen Mingxian; Hu Qingli (Chinese National Human Genome Centre), Review and Perspective of the Bioethics Development in China

Session II: Social, economic, environmental, ethical (etc.) implications

Sarah Cunningham-Burley (Genomics Forum), “Social Science, Public Engagement and Genetic Databases: Lessons from Generation Scotland”
View Cunningham-Burley presentation

John Dupré (Egenis), “Conceptual issues in the interpretation of contemporary biology and their implications for defining intellectual property”
View Dupre presentation

Lu Lan (Hangzhou Dianzi University), “Chinese public views on use of biotechnology”
 
Qiu Xiangxing; Zhu Wei; Hu Qingli (Chinese National Human Genome Centre), “Some Further Considerations in the Ethics Guidelines on Stem Cell Research and Clinical Practice in China"

Session III:  Regulation and public policy
Chair: Prof. Qingli Hu

Søren Holm (Cesagen), “Clinically Relevant Findings in Biobank Research - When Should They be Fed Back to the Tissue Donors?”
View Holm presentation

Neva Haites (Genomics Forum), “Human Embryo Research - Informing Regulatory Policy”
View Haites presentation

Hu Qingli; Shen Mingxian (Chinese National Human Genome Centre), “Promoting the Positive Intervention Between Scientists and Ethicists in the Development of Bioethics Regulations"